JP2024100936A5 - - Google Patents

Download PDF

Info

Publication number
JP2024100936A5
JP2024100936A5 JP2024083619A JP2024083619A JP2024100936A5 JP 2024100936 A5 JP2024100936 A5 JP 2024100936A5 JP 2024083619 A JP2024083619 A JP 2024083619A JP 2024083619 A JP2024083619 A JP 2024083619A JP 2024100936 A5 JP2024100936 A5 JP 2024100936A5
Authority
JP
Japan
Prior art keywords
nucleic acid
acid sequence
utr
absent
seq
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024083619A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024100936A (ja
Filing date
Publication date
Priority claimed from JP2021533524A external-priority patent/JP2022512395A/ja
Application filed filed Critical
Publication of JP2024100936A publication Critical patent/JP2024100936A/ja
Publication of JP2024100936A5 publication Critical patent/JP2024100936A5/ja
Pending legal-status Critical Current

Links

JP2024083619A 2018-12-12 2024-05-22 分泌治療モダリティを送達するためのアネロソーム Pending JP2024100936A (ja)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US201862778866P 2018-12-12 2018-12-12
US201862778869P 2018-12-12 2018-12-12
US62/778,866 2018-12-12
US62/778,869 2018-12-12
JP2021533524A JP2022512395A (ja) 2018-12-12 2019-12-12 分泌治療モダリティを送達するためのアネロソーム
PCT/US2019/065919 WO2020123773A2 (en) 2018-12-12 2019-12-12 Anellosomes for delivering secreted therapeutic modalities

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2021533524A Division JP2022512395A (ja) 2018-12-12 2019-12-12 分泌治療モダリティを送達するためのアネロソーム

Publications (2)

Publication Number Publication Date
JP2024100936A JP2024100936A (ja) 2024-07-26
JP2024100936A5 true JP2024100936A5 (cg-RX-API-DMAC10.html) 2024-10-31

Family

ID=69160343

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021533524A Pending JP2022512395A (ja) 2018-12-12 2019-12-12 分泌治療モダリティを送達するためのアネロソーム
JP2024083619A Pending JP2024100936A (ja) 2018-12-12 2024-05-22 分泌治療モダリティを送達するためのアネロソーム

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2021533524A Pending JP2022512395A (ja) 2018-12-12 2019-12-12 分泌治療モダリティを送達するためのアネロソーム

Country Status (11)

Country Link
US (2) US20230048858A1 (cg-RX-API-DMAC10.html)
EP (1) EP3894568A2 (cg-RX-API-DMAC10.html)
JP (2) JP2022512395A (cg-RX-API-DMAC10.html)
KR (1) KR20210131309A (cg-RX-API-DMAC10.html)
CN (1) CN113631717A (cg-RX-API-DMAC10.html)
AU (1) AU2019396520A1 (cg-RX-API-DMAC10.html)
BR (1) BR112021009379A2 (cg-RX-API-DMAC10.html)
CA (1) CA3119531A1 (cg-RX-API-DMAC10.html)
IL (1) IL283778A (cg-RX-API-DMAC10.html)
MX (1) MX2021006943A (cg-RX-API-DMAC10.html)
WO (1) WO2020123773A2 (cg-RX-API-DMAC10.html)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11624061B2 (en) 2017-04-28 2023-04-11 Agrospheres, Inc. Compositions and methods for enzyme immobilization
BR112020005803A2 (pt) 2017-09-25 2020-12-01 Agrospheres, Inc. composições e métodos para produção e administração moduláveis de produtos biológicos
JP2022513459A (ja) * 2018-12-12 2022-02-08 フラッグシップ パイオニアリング イノベーションズ ブイ, インコーポレイテッド タンパク質代替治療モダリティを送達するためのアネロソーム
CA3121528A1 (en) 2018-12-12 2020-06-18 Flagship Pioneering Innovations V, Inc. Anellosomes and methods of use
KR20230041686A (ko) * 2020-06-17 2023-03-24 플래그쉽 파이어니어링 이노베이션스 브이, 인크. 아넬로바이러스를 확인 및 특징화하는 방법 및 이의 용도
US20240000914A1 (en) * 2020-10-29 2024-01-04 Flagship Pioneering Innovations V, Inc. Chicken anemia virus (cav)-based vectors
WO2022170195A1 (en) * 2021-02-08 2022-08-11 Flagship Pioneering Innovations V, Inc. Hybrid aav-anellovectors
EP4337235A4 (en) * 2021-05-12 2025-07-02 Flagship Pioneering Innovations V Inc ANELLOVECTORS AND METHODS OF USE
CN118284411A (zh) * 2021-10-12 2024-07-02 旗舰先锋创新V股份有限公司 新颖的指环载体组合物和方法
MX2024004492A (es) * 2021-10-12 2024-05-31 Flagship Pioneering Innovations V Inc Composiciones y metodos de anellovector novedosos.
TW202430215A (zh) 2022-12-14 2024-08-01 美商旗艦先鋒創新有限責任(Vii)公司 用於將治療劑遞送至骨之組成物和方法
TW202529819A (zh) 2023-10-13 2025-08-01 美商旗艦先鋒創新公司 組織特異性指環載體(anellovector)遞送
CN117695410B (zh) * 2024-02-06 2024-05-03 中国人民解放军军事科学院军事医学研究院 CRISPR/Cas9纳米抗菌剂及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6395472B1 (en) * 1999-02-05 2002-05-28 Abbott Laboratories Methods of utilizing the TT virus
CN111206032B (zh) * 2013-12-12 2024-07-19 布罗德研究所有限公司 用于基因组编辑的crispr-cas系统和组合物的递送、用途和治疗应用
EP3359663A4 (en) * 2015-09-24 2019-08-14 The Trustees of The University of Pennsylvania COMPOSITION AND METHOD FOR THE TREATMENT OF A COMPLEMENT-MEDIATED DISEASE
CA3066750A1 (en) * 2017-06-13 2018-12-20 Flagship Pioneering Innovations V, Inc. Compositions comprising curons and uses thereof
KR20200067195A (ko) * 2017-10-18 2020-06-11 리젠엑스바이오 인크. 완전-인간 번역후 변형된 항체 치료제

Similar Documents

Publication Publication Date Title
JP2024099834A5 (cg-RX-API-DMAC10.html)
JP2024099833A5 (cg-RX-API-DMAC10.html)
JP2024102242A5 (cg-RX-API-DMAC10.html)
JP2024088642A5 (cg-RX-API-DMAC10.html)
AU2026202070A1 (en) Modified AAV capsid polypeptides for treatment of muscular diseases
JP2017079759A5 (cg-RX-API-DMAC10.html)
Sanchez-Pescador et al. Use of unpurified synthetic deoxynucleotide primers for rapid dideoxynucleotide chain termination sequencing
JP2023534131A5 (cg-RX-API-DMAC10.html)
JP2020508685A5 (cg-RX-API-DMAC10.html)
JP2024520528A5 (cg-RX-API-DMAC10.html)
JP2003522514A5 (cg-RX-API-DMAC10.html)
JP2023549357A5 (cg-RX-API-DMAC10.html)
EP1437400A3 (en) Artificial chromosome constructs containing nucleic acid sequences capable of directing the formation of a recombinant rna-virus
JP2003503355A5 (cg-RX-API-DMAC10.html)
JP2024500036A5 (cg-RX-API-DMAC10.html)
JP2005509420A5 (cg-RX-API-DMAC10.html)
JP2024513907A5 (cg-RX-API-DMAC10.html)
JPH0322975A (ja) 新規な逆転写酵素活性を有する蛋白
Ward et al. Structural homologies between RNA gene segments 10 and 11 from UK bovine, simian SA11, and human Wa rotaviruses
CN108018267A (zh) 一种靶向表观基因调控抗乙型肝炎病毒分子HBx1C及其应用
JP2024520691A5 (cg-RX-API-DMAC10.html)
JP2023087682A5 (cg-RX-API-DMAC10.html)
JP2021508496A5 (cg-RX-API-DMAC10.html)
JPWO2023214512A5 (cg-RX-API-DMAC10.html)
JPWO2023120658A5 (cg-RX-API-DMAC10.html)